Literature DB >> 30546397

Differential roles of p38 MAPK and ERK1/2 in angiopoietin-2-mediated rat pulmonary microvascular endothelial cell apoptosis induced by lipopolysaccharide.

Shi Li1, Mingmei Zhong1, Yuan Yuan2, Lin Zhang1.   

Abstract

Angiopoietin-2 (Ang-2) is a Tie-2 ligand that destabilizes vascular structures, enhances vascular permeability and induces vascular regression and endothelial cell apoptosis. Although there is evidence for the involvement of the Ang/Tie2 axis in acute lung injury (ALI), the underlying mechanisms involved in Ang-2-induced cell apoptosis are not well understood. In this study, whether Ang-2 contributes to microvascular endothelial cell injury and mediates lipopolysaccharide (LPS)-induced endothelial cell apoptosis and its associated signaling pathways was investigated. Exposure of rat pulmonary microvascular endothelial cells (RPMVECs) to LPS, Ang-2 and related inhibitors was performed to measure the expression levels of Ang-2, the activation of mitogen-activated protein kinases (MAPKs), the phosphorylation of extracellular signal-regulated kinase (ERK)1/2, and expression of the apoptosis-related proteins Bax and Bcl-2 using western blotting, reverse transcription-quantitative polymerase chain reaction, flow cytometry and fluorescence microscopy. The expression of Ang-2 in the RPMVECs was increased by LPS independent of time. The phosphorylation of p38 MAPK and ERK1/2 was significantly upregulated and the activation of apoptosis-related proteins Bax and Bcl was mediated by Ang-2. In addition, inhibition of the p38 pathway by SB203580 attenuated the Ang-2-mediated cell apoptosis, but inhibition of the ERK1/2 pathway by PD98059 exerted an anti-apoptotic effect against Ang-2. In conclusion, LPS-induced apoptosis is partly mediated via stimulation of p38 and ERK1/2 signaling pathways, where Ang-2 acts an inflammation-related factor to participate in the course of cell apoptosis in RPMVECs.

Entities:  

Keywords:  angiopoietin-2; apoptosis; lipopolysaccharide; pulmonary microvascular endothelial cells

Year:  2018        PMID: 30546397      PMCID: PMC6256857          DOI: 10.3892/etm.2018.6810

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability.

Authors:  Fiemu E Nwariaku; Patricia Rothenbach; Zijuan Liu; Xudong Zhu; Richard H Turnage; Lance S Terada
Journal:  J Appl Physiol (1985)       Date:  2003-07-03

3.  Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period.

Authors:  Gavin Thurston; Quan Wang; Fabienne Baffert; John Rudge; Nicholas Papadopoulos; Danielle Jean-Guillaume; Stanley Wiegand; George D Yancopoulos; Donald M McDonald
Journal:  Development       Date:  2005-06-15       Impact factor: 6.868

4.  Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.

Authors:  Ashish Agrawal; Michael A Matthay; Kirsten N Kangelaris; John Stein; Jeffrey C Chu; Brandon M Imp; Alfredo Cortez; Jason Abbott; Kathleen D Liu; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

5.  Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury.

Authors:  Huiying Liu; Xiaojun Liang; Dadong Wang; Hongquan Zhang; Lingling Liu; Hongguang Chen; Yuan Li; Qing Duan; Keliang Xie
Journal:  Shock       Date:  2015-05       Impact factor: 3.454

6.  Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity.

Authors:  Joshua S Davis; Tsin W Yeo; Kim A Piera; Tonia Woodberry; David S Celermajer; Dianne P Stephens; Nicholas M Anstey
Journal:  Crit Care       Date:  2010-05-18       Impact factor: 9.097

7.  Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.

Authors:  Rania Harfouche; Haroutioun M Hasséssian; Yang Guo; Valérie Faivre; Coimbatore B Srikant; George D Yancopoulos; Sabah N A Hussain
Journal:  Microvasc Res       Date:  2002-07       Impact factor: 3.514

8.  Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock.

Authors:  Naoyuki Matsuda; Yasuo Takano; Shun-Ichiro Kageyama; Noboru Hatakeyama; Kiyoshi Shakunaga; Isao Kitajima; Mitsuaki Yamazaki; Yuichi Hattori
Journal:  Cardiovasc Res       Date:  2007-06-05       Impact factor: 10.787

9.  Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling.

Authors:  Nobuhiro Kanaji; Tadashi Sato; Amy Nelson; Xingqi Wang; Yingji Li; Miok Kim; Masanori Nakanishi; Hesham Basma; Joel Michalski; Maha Farid; Michael Chandler; William Pease; Amol Patil; Stephen I Rennard; Xiangde Liu
Journal:  J Inflamm Res       Date:  2011-09-15

10.  Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis.

Authors:  Philipp Kümpers; Matijs van Meurs; Sascha David; Grietje Molema; Johan Bijzet; Alexander Lukasz; Frank Biertz; Hermann Haller; Jan G Zijlstra
Journal:  Crit Care       Date:  2009-05-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.